CRNX Operating Expenses

Crinetics Pharmaceuticals Inc · Operating Expenses

CRNX logo

CRNX Operating Expenses

Latest reported$590.89M
CRNX TTM Operating Expenses ($9.13M → $590.89M)
High-resolution chart · PNG

CRNX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crinetics Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
590,891,000
563,611,000
524,465,000
412,817,000
295,980,000
249,019,000
211,422,000
200,321,000
233,752,000
204,553,000
181,041,000
212,228,000
196,817,000
186,318,000
172,619,000
156,320,000
118,635,000
80,753,000
49,129,000
38,954,000
51,178,000
62,505,000
74,953,000
68,376,000
65,154,000
61,570,000
53,832,000
48,049,000
40,890,000
33,228,000
28,710,000
21,780,000
16,084,000
12,044,000
9,127,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.